ClinicalTrials.govpublic full text
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
metastatic breast cancer, advanced breast cancer, metastatic castration resistant prostate cancer, metastatic renal cell cancer, non-small cell lung cancer, thyroid cancer, advanced/metastatic non-small cell lung cancer, advanced gastric cancer, gastrointestinal stromal tumor, hepatocellular carcinoma, pancreatic islet cell carcinoma, pancreatic neuroendocrine tumor
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 807674
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.